What Is Monoclonal Antibody Therapy?

A Proven Treatment for COVID-19 Infections.

The Monoclonal Antibody treatment can block the SARS-CoV-2 virus (the virus that causes COVID-19) from entering cells in your body and limit the amount of the virus within your body. This means you may have milder symptoms and may decrease the likelihood of you needing to stay in the hospital.

If you are at risk for serious COVID-19 and you have tested positive for COVID-19 or have been in close contact with someone who has tested positive, you may want to consider a monoclonal antibody (mAb) treatment. You may qualify for this promising COVID-19 treatment depending on your age, health history, and how long you have had symptoms. You do not need to have symptoms or test positive to qualify for mAb treatment if you are at high risk for serious COVID-19.



Benifits of Monoclonal Antibody Treatment

Working Together we can beat the COVID-19 Virus

The mAb treatment may help people who:

  • Are at high risk of getting more serious symptoms and
  • Have a positive COVID-19 test with symptoms for 10 days or less or
  • Have been in close contact with someone who has recently tested positive

Visit the page Who is at high risk for serious COVID-19? to learn more.

For More Information on Monoclonal Antibody Therapy:

As the United States and world continue to fight the COVID-19 pandemic, America’s biopharmaceutical research companies continue to do our part in fighting this deadly virus. Decades of scientific innovation have allowed biopharmaceutical researchers to respond quickly and continue to research and develop treatments and vaccines for COVID-19. Importantly, the best strategy to prevent infection against COVID-19 is to get vaccinated. Three vaccines are currently available for protection against COVID-19, one of which was recently approved by The U.S. Food and Drug Administration (FDA) for use in certain populations. These vaccines are safe and have been administered to over a hundred million Americans, and billions around the world. To date, one antiviral is also currently approved by the FDA for use in patients 12 years of age and older for the treatment of COVID-19, which has the ability to speed recovery time by up to 5 days.


This website and its content are the exclusive property of The Physician Associate Interdisciplinary Clinic

© Copyright 2021. All rights reserved.